ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 264

Ethnicity-Related Differences in the Clinical Presentation of Sarcoidosis in Spain (SARCOGEAS-SEMI Registry)

Roberto Pérez-Alvarez1, Soledad Retamozo2,3, Belchin Kostov4, Andrés González García5, Carmen Yllera Gutiérrez6, Miguel López Dupla7, Esperanza Bueno Juana8, Ana Alguacil9, Juan Escobedo Palau10, Francisco Javier Rascón11, Jose Salvador Garcia Morillo12, Carles Tolosa Vilella13, Eva Fonseca Aizpuru14, Mariona Bonet15, Naya Faro Minguez16, Anna Sánchez Biosca17, Ana Belén Madroñero18, Cristina Soler I Ferrer19, Enrique Peral Gutiérrez De Ceballos20, Jorge Francisco Gómez Cerezo21, Gracia Cruz Caparrós22, Patricia Perez Guerrero23, Sergio Rodríguez Fernández24, Alberto Gato Diez25, Blanca Pinilla26, Miriam Akasbi27, Angel Robles28, Inmaculada Ojeda29, María José Vives30, María Penadés Vidal31, Moisés De Vicente32, César Morcillo33, Lucio Pallarés11, Pilar Brito-Zerón3,34 and SARCOGEAS Registry, GEAS-SEMI, 1Department of Internal Medicine, Hospital Alvaro Cunqueiro, Vigo, Vigo, Spain, 2Rheumatology Unit, Hospital Privado Centro Médico de Córdoba, Postgraduate Career of Rheumatology Catholic University of Córdoba, Fundación para las Ciencias Biomédicas de Córdoba (FUCIBICO), Cordoba, Argentina, 3Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Barcelona, Spain, 4Primary Care Research Group, IDIBAPS, Centre d’Assistència Primària ABS Les Corts, CAPSE, Barcelona, Barcelona, Spain, 5Department of Internal Medicine, Hospital Ramón y Cajal, Madrid, Madrid, Spain, 6Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Oviedo, Spain, 7Department of Internal Medicine, Hospital Universitari Joan XXIII, Tarragona, Tarragona, Spain, 8Department of Internal Medicine, Hospital Clínico, Zaragoza, Zaragoza, Spain, 9Department of Internal Medicine, Hospital Virgen de la Salud, Toledo, Toledo, Spain, 10Department of Internal Medicine, Hospital Universitario Miguel Servet, Zaragoza, Zaragoza, Spain, 11Department of Internal Medicine, Hospital Son Espases. Palma de Mallorca, Palma de Mallorca, Spain, 12Department of Internal Medicine, Hospital Virgen del Rocio, Sevilla, Sevilla, Spain, 13Department of Internal Medicine, Hospital Parc Taulí, Sabadell, Sadabell, Spain, 14Department of Internal Medicine, Hospital de Cabueñes, Gijón, Gijón, Spain, 15Department of Internal Medicine, Althaia, Xarxa Assistencial de Manresa, Manresa, Spain, 16Department of Internal Medicine, Hospital Clínico San Cecilio, Granada, Granada, Spain, 17Department of Internal Medicine, Hospital de Santa Coloma de Gramenet Barcelona, Barcelona, Spain, 18Department of Internal Medicine, Hospital General San Jorge, Huesca, Huesca, Spain, 19Department of Internal Medicine, Hospital de Santa Caterina, Girona, Girona, Spain, 20Department of Internal Medicine, Hospital Virgen Macarena, Sevilla, Sevilla, Spain, 21Department of Internal Medicine, Hospital Infanta Sofía, San Sebastián, San Sebastian, Spain, 22Department of Internal Medicine, Hospital de Poniente El Ejido, Almería, Almería, Spain, 23Department of Internal Medicine, Hospital Universitario Puerta del Mar, Cádiz, Cadiz, Spain, 24Department of Internal Medicine, Hospital da Barbanza, A Coruña, A Coruña, Spain, 25Department of Internal Medicine, Complejo Hospitalario Albacete, Albacete, Albacete, Spain, 26Department of Internal Medicine, Hospital Gregorio Marañón, Madrid, Madrid, Spain, 27Department of Internal Medicine, Hospital Infanta Leonor, Madrid, Madrid, Spain, 28Department of Internal Medicine, Hospital La Paz, Madrid, Madrid, Spain, 29Department of Internal Medicine, Hospital Valle del Guadiato, Córdoba, Cordoba, Spain, 30Department of Internal Medicine, Parc Sanitari San Joan de Déu, San Boi de Llobregat, Barcelona, Spain, 31Department of Internal Medicine, Hospital De Manises, Valencia, Valencia, Spain, 32Department of Internal Medicine, Hospital Nuestra Señora del Prado, Talavera, Talavera, Spain, 33Department of Medicine, Hospital CIMA-Sanitas, Barcelona, Barcelona, Spain, 34Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona., Bacelona, Spain

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ethnic studies and sarcoidosis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Miscellaneous Rheumatic and Inflammatory Diseases - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: To evaluate the influence of ethnicity on the clinical presentation of sarcoidosis in a large multicenter cohort from Southern Europe.

Methods: In January 2016, the Autoimmune Diseases Study Group (GEAS-SEMI) created a national registry (SARCOGEAS) of patients with sarcoidosis. Sarcoidosis was diagnosed in agreement with the criteria proposed by the American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) 1999 statement on sarcoidosis. Organ involvement was retrospectively determined in each patient at the time of diagnosis using the 2014 WASOG organ assessment instrument. Ethnicity was classified according to the FDA classification. Two outcomes (association with neoplasia and death) were assessed at the end of follow-up.

Results: The cohort consisted of 979 patients (85% biopsy-proven), including 562 (57%) women and 417 (43%) men, with a mean age at diagnosis of 47.02 ± 15.44 years. With respect to the FDA ethnic classification, 858 (88%) patients were classified as White, 83 (8%) as Hispanic, 21 (2%) as Black/African American and 17 (2%) as Asian. Epidemiologically, the lowest frequency of women was reported in Blacks/African Americans (24% vs. 58%W, 59%A and 60%H, p=0.018) Radiologically, the highest frequency of radiological stages involving the lung parenchyma was found in Hispanics (79% vs. 71%BAA, 67%W and 56%A, p=0.041). With respect to extrathoracic WASOG involvements, the highest frequencies of cutaneous involvement were found in Hispanics and Whites (41% and 35% vs. 12%A and 9%BAA, p=0.011), ocular involvement in Blacks/African Americans (29%% vs. 14%H, 11%W and 0%A, p=0.021), liver involvement in Blacks/African Americans (38% vs. 16%H, 12%W and 0%A, p=0.021), and kidney involvement in Blacks/African Americans and Asians (14% vs. 11% vs 5%W and 1%H, p=0.037) (Figure 1). After a mean follow-up of 87.9 months, neoplasia was reported in 112 (11%) patients and 91 (9%) patients died. Sarcoidosis was more frequently related to neoplasia in Whites (13% vs. 6%H, 0%BAA and 0%A, p=0.042), who also had the highest mortality rate (10% vs. 5%BAA, 1%H and 0%A, p=0.015).

Conclusion: In a predominantly White Southern European population of patients diagnosed with sarcoidosis, ethnicity played a significant role in the presentation and prognosis of the disease even after taking into account the lower frequencies of ethnicities associated with poor outcomes (Black/African Americans and Hispanics). Consideration of ethnic disparities in the clinical presentation of sarcoidosis may be essential in reaching an early diagnosis, the search for histopathological confirmation and the prompt introduction of specific therapy in Mediterranean patients with sarcoidosis.


Disclosure: R. Pérez-Alvarez, None; S. Retamozo, None; B. Kostov, None; A. González García, None; C. Yllera Gutiérrez, None; M. López Dupla, None; E. Bueno Juana, None; A. Alguacil, None; J. Escobedo Palau, None; F. J. Rascón, None; J. S. Garcia Morillo, None; C. Tolosa Vilella, None; E. Fonseca Aizpuru, None; M. Bonet, None; N. Faro Minguez, None; A. Sánchez Biosca, None; A. B. Madroñero, None; C. Soler I Ferrer, None; E. Peral Gutiérrez De Ceballos, None; J. F. Gómez Cerezo, None; G. Cruz Caparrós, None; P. Perez Guerrero, None; S. Rodríguez Fernández, None; A. Gato Diez, None; B. Pinilla, None; M. Akasbi, None; A. Robles, None; I. Ojeda, None; M. J. Vives, None; M. Penadés Vidal, None; M. De Vicente, None; C. Morcillo, None; L. Pallarés, None; P. Brito-Zerón, None.

To cite this abstract in AMA style:

Pérez-Alvarez R, Retamozo S, Kostov B, González García A, Yllera Gutiérrez C, López Dupla M, Bueno Juana E, Alguacil A, Escobedo Palau J, Rascón FJ, Garcia Morillo JS, Tolosa Vilella C, Fonseca Aizpuru E, Bonet M, Faro Minguez N, Sánchez Biosca A, Madroñero AB, Soler I Ferrer C, Peral Gutiérrez De Ceballos E, Gómez Cerezo JF, Cruz Caparrós G, Perez Guerrero P, Rodríguez Fernández S, Gato Diez A, Pinilla B, Akasbi M, Robles A, Ojeda I, Vives MJ, Penadés Vidal M, De Vicente M, Morcillo C, Pallarés L, Brito-Zerón P. Ethnicity-Related Differences in the Clinical Presentation of Sarcoidosis in Spain (SARCOGEAS-SEMI Registry) [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/ethnicity-related-differences-in-the-clinical-presentation-of-sarcoidosis-in-spain-sarcogeas-semi-registry/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ethnicity-related-differences-in-the-clinical-presentation-of-sarcoidosis-in-spain-sarcogeas-semi-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology